To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

PHASE3RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

March 31, 2025

Conditions
Glabellar Lines
Interventions
DRUG

HU-045

"HU-045 is a medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.~White powder~Other Names:~IncobotulinumtoxinA"

DRUG

Xeomin®

"Xeomin® is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.~Other Names:~IncobotulinumtoxinA"

Trial Locations (1)

Unknown

RECRUITING

Kangbuk Samsung Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Huons Biopharma

INDUSTRY

NCT06205797 - To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III) | Biotech Hunter | Biotech Hunter